EGFR and non-small cell lung carcinoma: Regrettably, both in the non-squamous NSCLC EGFR mutant (43 patients) and in the squamous-NSCLC cohort (27 patients), the activity was modest, with ORRs of 11.6% and 11.1%, respectively [53].